Mark Peakman Selected Research

Hyperglycemia

10/2008

CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Peakman Research Topics

Disease

65	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 06/2002
15	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2004
7	Infections 10/2022 - 07/2003
5	Disease Progression 06/2023 - 04/2012
4	Neoplasms (Cancer) 01/2018 - 12/2013
4	Inflammation (Inflammations) 10/2017 - 05/2012
3	Communicable Diseases (Infectious Diseases) 03/2016 - 04/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2022 - 01/2020
2	Human Influenza (Influenza) 01/2017 - 03/2016
2	Insulinoma 04/2016 - 08/2011
2	Whooping Cough (Pertussis) 07/2006 - 12/2005
2	Anthrax 07/2006 - 12/2005
2	Plague (Bubonic Plague) 07/2006 - 12/2005
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 03/2024
1	Enterovirus Infections 10/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Infectious Mononucleosis (Glandular Fever) 01/2020
1	Cognitive Dysfunction 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Ketosis 01/2018
1	Ankylosing Spondylitis 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017
1	Celiac Disease (Celiac Sprue) 01/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2013
1	Tertiary Lymphoid Structures 09/2010
1	Hypersensitivity (Allergy) 03/2009
1	Hyperglycemia 10/2008

Drug/Important Bio-Agent (IBA)

19	Peptides (Polypeptides)IBA 01/2022 - 02/2004
19	AntigensIBA 01/2022 - 06/2002
18	Insulin (Novolin)FDA Link 09/2023 - 10/2008
15	AutoantigensIBA 01/2022 - 12/2004
13	EpitopesIBA 01/2021 - 12/2004
9	AutoantibodiesIBA 03/2024 - 01/2009
7	preproinsulinIBA 01/2018 - 10/2008
7	CytokinesIBA 10/2017 - 07/2003
6	ProinsulinIBA 01/2022 - 10/2006
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 08/2011
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 10/2008
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2010
3	AntibodiesIBA 03/2024 - 01/2016
3	C-PeptideIBA 03/2024 - 10/2014
3	RNA (Ribonucleic Acid)IBA 06/2023 - 09/2011
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 09/2015
3	Abatacept (Orencia)FDA Link 01/2020 - 04/2014
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018 - 04/2016
3	Interleukin-10 (Interleukin 10)IBA 05/2012 - 01/2005
2	HLA-A*02:01 antigenIBA 01/2020 - 01/2012
2	HLA-A Antigens (HLA-A)IBA 01/2018 - 01/2018
2	Protein Sorting Signals (Signal Peptide)IBA 01/2018 - 07/2012
2	Indicators and Reagents (Reagents)IBA 01/2018 - 09/2015
2	HLA-DQ Antigens (HLA-DQ)IBA 11/2017 - 01/2014
2	InterleukinsIBA 10/2017 - 08/2011
2	Therapeutic UsesIBA 10/2014 - 04/2006
2	HLA-A24 AntigenIBA 01/2013 - 07/2012
2	Interleukin-8 (Interleukin 8)IBA 10/2007 - 07/2003
2	Interleukin-6 (Interleukin 6)IBA 10/2007 - 07/2003
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2007 - 07/2003
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2007 - 07/2003
2	VaccinesIBA 07/2006 - 12/2005
1	Blood Proteins (Serum Proteins)IBA 11/2023
1	IFIH1 Interferon-Induced HelicaseIBA 10/2022
1	Pattern Recognition ReceptorsIBA 10/2022
1	HLA-DRB1*04:01 antigenIBA 01/2022
1	InterferonsIBA 01/2022
1	aluminum sulfate (alum)IBA 01/2020
1	tyramine-deoxysorbitolIBA 01/2020
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	Immunodominant EpitopesIBA 01/2018
1	Zinc Transporter 8IBA 01/2018
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 11/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2016
1	Protein Isoforms (Isoforms)IBA 04/2016
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 04/2016
1	Histocompatibility Antigens Class IIIBA 01/2016
1	Coloring Agents (Dyes)IBA 09/2015
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2014
1	Glutens (Glutelin)IBA 01/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2013
1	Sirolimus (Rapamycin)FDA Link 08/2013
1	Drug CombinationsIBA 08/2013
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2013
1	Interleukin-2 (IL2)IBA 05/2012
1	Interleukin-17 (Interleukin 17)IBA 08/2011
1	EnzymesIBA 08/2011
1	Omalizumab (Xolair)FDA Link 03/2009
1	Rituximab (Mabthera)FDA Link 03/2009
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2009
1	ChemokinesIBA 10/2007
1	lymphotactinIBA 10/2007
1	adenovirus receptorIBA 10/2007
1	Integrin beta3 (GPIIIa)IBA 10/2007

Therapy/Procedure

16	Immunotherapy 01/2022 - 02/2004
12	Therapeutics 01/2021 - 04/2006
3	Islets of Langerhans Transplantation 01/2021 - 08/2013
1	Glycemic Control 01/2020
1	Precision Medicine 01/2019
1	Cell Transplantation 01/2016
1	Withholding Treatment 04/2014